We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$437M
AUM Growth
+$49.4M
Cap. Flow
-$2.17M
Cap. Flow %
-0.5%
Top 10 Hldgs %
60.21%
Holding
38
New
7
Increased
8
Reduced
12
Closed
7

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$16.9M
2
EW icon
Edwards Lifesciences
EW
+$13.4M
3
ILMN icon
Illumina
ILMN
+$10.1M
4
THC icon
Tenet Healthcare
THC
+$9.06M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.26M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$22.7M
2
BIIB icon
Biogen
BIIB
+$11.4M
3
CI icon
Cigna
CI
+$8.94M
4
MRK icon
Merck
MRK
+$5.51M
5
SAGE
Sage Therapeutics
SAGE
+$4.53M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$51.2M 11.7%
596,036
-287,070
-33% -$22.7M
INCY icon
2
Incyte
INCY
$23.4B
$33.1M 7.56%
411,487
-7,307
-2% -$559K
CAH icon
3
Cardinal Health
CAH
$53.5B
$27.2M 6.22%
353,872
-4,828
-1% -$367K
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$27.2M 6.21%
377,669
+24,042
+7% +$1.81M
ELV icon
5
Elevance Health
ELV
$80.9B
$24.5M 5.6%
47,777
+1,745
+4% +$886K
MRK icon
6
Merck
MRK
$315B
$22.1M 5.06%
199,300
-53,859
-21% -$5.51M
MDT icon
7
Medtronic
MDT
$106B
$21.6M 4.93%
277,435
+7,478
+3% +$606K
ZBH icon
8
Zimmer Biomet
ZBH
$17.6B
$19.6M 4.49%
154,116
-11,964
-7% -$1.39M
BIIB icon
9
Biogen
BIIB
$30.4B
$19.4M 4.43%
70,039
-40,191
-36% -$11.4M
LH icon
10
Labcorp
LH
$23.2B
$17.5M 4.01%
+86,713
New +$16.9M
BMRN icon
11
BioMarin Pharmaceuticals
BMRN
$11.5B
$16M 3.67%
155,009
+45,405
+41% +$4.26M
CNC icon
12
Centene
CNC
$32.8B
$15.2M 3.47%
184,901
-16,654
-8% -$1.36M
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
$13.6M 3.12%
106,207
+21,477
+25% +$2.77M
BSX icon
14
Boston Scientific
BSX
$65.4B
$13.6M 3.12%
294,784
-92,400
-24% -$4M
BRKR icon
15
Bruker
BRKR
$8.86B
$13.1M 3%
191,982
-45,976
-19% -$2.92M
EW icon
16
Edwards Lifesciences
EW
$49.4B
$13M 2.97%
+174,252
New +$13.4M
QGEN icon
17
Qiagen
QGEN
$8.49B
$11.6M 2.66%
220,178
+27,725
+14% +$1.37M
BAX icon
18
Baxter International
BAX
$11.7B
$11.3M 2.58%
221,088
+52,060
+31% +$2.8M
ILMN icon
19
Illumina
ILMN
$28.2B
$9.6M 2.2%
+48,830
New +$10.1M
THC icon
20
Tenet Healthcare
THC
$16.8B
$9.56M 2.19%
+195,954
New +$9.06M
CI icon
21
Cigna
CI
$74.5B
$7.37M 1.69%
22,252
-28,265
-56% -$8.94M
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
$7.17M 1.64%
173,842
-74,807
-30% -$3.03M
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.15B
$6.72M 1.54%
15,988
+4,000
+33% +$1.61M
IONS icon
24
Ionis Pharmaceuticals
IONS
$8.99B
$5.34M 1.22%
141,373
-22,850
-14% -$961K
CVS icon
25
CVS Health
CVS
$137B
$4.05M 0.93%
43,443
– –
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2022 Portfolio in Review

As of Q4 2022, Sector Gamma AS held 38 positions worth $437M, up 13% from $388M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q4 2022 filing shows 7 new, 8 increased, 12 reduced and 7 closed positions. Its largest new stake was Labcorp: 86,713 shares worth $17.5M. The largest sale was Gilead Sciences, an estimated $22.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q4 2022 buy was Labcorp: 86,713 shares worth $17.5M.
  • Sector Gamma AS added most to BioMarin Pharmaceuticals in Q4 2022, an estimated $4.26M increase.
  • Sector Gamma AS's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $22.7M.
  • Sector Gamma AS fully exited Sage Therapeutics in Q4 2022, selling an estimated $4.53M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $437M portfolio in Q4 2022.
  • Sector Gamma AS opened 7 new positions and closed 7 in Q4 2022.
  • Sector Gamma AS's portfolio value rose 13% quarter-over-quarter to $437M.

Based on Sector Gamma AS's 13F filing for Q4 2022, filed 7 Feb 2023.